DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1

Molecular Cell

Volumn 1, Issue 4, 1998, Pages 543-551

  Kasibhatla, Shailaja ^a   Brunner, Thomas ^a,b   Genestier, Laurent ^a   Echeverri, Fernando ^a   Mahboubi, Artin ^a   Green, Douglas R ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CHEMISTRY; CYTOLOGY; DNA DAMAGE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; LEUKEMIA CELL LINE; METABOLISM; MOLECULAR GENETICS; PROMOTER REGION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DNA DAMAGE; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

EID: 0032014073     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80054-4     Document Type: Article

References (79)

1. Alderson, M.R., Tough, T.W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K.A., Goodwin, R.G., Smith, C.A., Ramsdell, F., and Lynch, D.H. (1995). Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77.
2. Amati, B., Littlewood, T.D., Evan, G.I., and Land, H. (1993). The c-Myc protein induces cell cyle progression and apoptosis through dimerization with Max. EMBO J. 12, 5083-5087.
3. Anel, A., Buferne, M., Boyer, C., Schnitt-Verhulst, A.-M., and Golstein, P. (1994). T cell receptor-induced Fas-ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24, 2469-2476.
4. Ashwell, J.D., Cunningham, R.E., Noguchi, P.D., and Hernandez, D. (1987). Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165, 173-194.
5. Beg, A.A., and Baltimore, D. (1996). An essential role for the NFκB in preventing TNF-α-induced death. Science 274, 782-784.
6. Bessho, R. (1994). Pyrrolidinedithiocarbamate, a potent inhibitor of nuclear factor κB (NFκB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol. 48, 1883-1889.
7. Boland, M., Foster, S., and O'Neill, L. (1997). Daunorubicin activates NFκB and induces κB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J. Biol. Chem. 272, 12952-12960.
8. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L., Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
9. Boldin, M.P., Goncharev, T.M., Goltsev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85, 803-815.
10. Brunner, T., Mogil, R.J., LaFace, D., Yoo, N.J., Machboubi, A., Echeverri, F., Martin, S.J., Force, W.R., Lynch, D.H., Ware, C.F., and Green, D.R. (1995). Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444.
11. Brunner, T., Yoo, N.J., LaFace, D., Ware, C.F., and Green, D.R. (1996). Activation-induced cell death in murine T cell hybridomas: differential regulation of Fas (CD95) and Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 9, 1017-1026.
12. Chen, Y.-R., Meyer, C., and Tan, T.-H. (1996). Persistent activation of c-Jun N-terminal kinase 1 (JNK1)in γ radiation-induced apoptosis. J. Biol. Chem. 271, 631-634.
13. Chen, Y.-R., Wang, X., Templeton, D., Davis, R., and Tan, T.-H. (1996). The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J. Biol. Chem. 271, 31929-31936.
14. Cifone, M.G., De Maria, R., Rocaioli, P., Rippo, M.R., Azuma, M., Lanier, L.L., Santoni, A., and Testi, R. (1993). Apoptotic signaling through CD95 (Fas/APO-1) activates an acidic sphingomyelinase. J. Exp. Med. 177, 1547-1552.
15. Derijard (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037.
16. Devary, Y., Gottlieb, R., Smeal, T., and Karin, M. (1992).The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71, 1081-1091.
17. Dhein, J., Walczak, H., Baeumler, C., Debatin, K.-M., and Krammer, P.H. (1995). Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
18. DiDonato, J., Mercurio, F., and Karin, M. (1996). Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol 15, 1295-1304.
19. Evan, G.I., Wyllie, A.H., Gilberts, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69, 119-128.
20. Faris, M., Kokot, N., Latinis, K., Kasibhatla, S., Green, D.R., Koretsky, G.A., and Nel, A. (1998). The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol. 160, 134-144.
21. Faris, M., Kokot, N., Lee, L., and Nel, A. (1996). Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in Jurkat T cells. J. Biol. Chem. 271, 27366-27373.
22. Friesen, C., Herr, I., Krammer, P.H., and Debatin, K.-M. (1996). Involvement of the CD95(APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2, 574-577.
23. Fritsche, M., Haessler, C., and Brandner, G. (1993). Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 8, 307-318.
24. Galle, P., Hofmann, W., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P., and Runkel, L. (1995). Involvement of the APO-1/ Fas(CD95) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
25. Giordano, C., Stassi, G., DeMaria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M.,Testi, R., and Galluzzo, A. (1997). Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960-963.
26. Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishioka, W., Brunner, T., Baier, G., Baier-Bitterlich, G., Byrd, C., Lang, F., Kolesnick, R., Altman, A., and Green, D. (1995). Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 2, 341-351.
27. Gupta, S., Campbell, D., Derijard, B., and Davis, R. (1995).Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267, 389-393.
28. Hermeking, H., and Eick, D. (1994). Mediation of c-Myc-induced apoptosis by p53. Science 265, 2091-2093.
29. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. (1993). Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135-2148.
30. Houghton, J.A., Harwood, F.G., and Tillman, D.M. (1997). Thymineless death in colon carcinoma cells is mediated via fas signaling. Proc. Natl. Acad. Sci. USA 94, 8144-8149.
31. Hueber, A.-O., Zornig, M., Lyon, D., Suda, T., Nagata, S., and Evan, G. (1997). Requirement for the CD95 receptor-ligand pathway on c-Myc-induced apoptosis. Science 278, 1305-1309.
32. Israel, A., LeBail, D., Hata, J., Piette, M., Kieran, F., Logeat, D., Wallach, M., and Kourilsky, P. (1989). TNF stimulates expression of mouse MHC class I genes by inducing an NK-κB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8, 3793-3800.
33. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for the human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
34. Janicke, R.U., Lin, X.Y., Lee, F.H.H., and Porter, A. (1996). Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced c-Myc-dependent apoptosis. Mol. Cell. Biol. 16, 5245-5253.
35. Ju, S.-T., Panka, D.J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D.H., Stanger, B.Z., and Marshak-Rothstein, A. (1995). Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
36. Kallunki, T., Su, B., Tsigelny, I., Sluss, H., Derijard, B., Moore, G., Davis, R., and Karin, M. (1994). JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8, 2996-3007.
37. Karin, M. (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
38. Kasibhatla, S., Nalefski, E., and Rao, A. (1993). Simultaneous involvement of all six predicted antigen binding loops of the T cell receptor in recognition of the MHC/antigen complex. J. Immunol. 151, 3140-3151.
39. Kaufmann, S. (1989). Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49, 5870-5878.
40. Kuerbitz, S.J., Plunkett, B.S., Walsh, W.V., and Kastan, M.B. (1992). Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89, 7492-7495.
41. Kyriakis, J., Banergee, P., Nikolakaki, E., Dai, T., Rubie, E., Ahmad, M., Avruch, J., and Woodgett, J. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.
42. Latinis, K., Carr, L., Peterson, E., Norian, L., Eliason, S., and Koretzky, G. (1997). Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158, 4602-4611.
43. Lee, W., Mitchell, P., and Tjian, R. (1987). Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752.
44. Lee, F., Hagler, J., Chen, Z., and Maniatis, T. (1997). Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88, 213-222.
45. Lenardo, M., and Baltimore, D. (1989) NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58, 227-229.
46. Lin, A., Minden, A., Martineto, H., Claret, F.-X., Carter, C.-L., Mercurio, F., Johnson, G., and Karin, M. (1995). Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268, 286-290.
47. Liu, D.-G., Smith, S.W., McLaughlin, K.A., Schwartz, L.M., and Osborne, B.A. (1994). Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367, 281-284.
48. Liu, Z.-G., Baskaran, C., Lea-Choe, E.T., Wood, L.D., Chen, Y., Karin, M., and Wang, J.Y.J. (1996). Three distinct signaling responses by murine fibroblasts to genotoxic stress. Nature 384, 273-276.
49. Liu, Z.G., Hsu, H., Goeddel, D.V., and Karin, M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NFκB activation prevents cell death. Cell 87, 565-576.
50. Livingstone (1995). ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14, 1785-1797.
51. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849.
52. Martin, S., Lennon, S., Bonham, A., and Cotter, T. (1990). Induction of apoptosis (programmed cell death) in human leukemic (HL-60) cells by inhibition of RNA or protein synthesis. J. Immunol 145, 1859-1867.
53. Mercurio, F., DiDonato, J., Rosette, C., and Karin, M. (1993). p105 and p98 precursor proteins play an active role in NFκB-mediated signal transduction. Genes Dev. 7, 705-718.
54. Minden, A., Lin, A., McMahon, M., Carter, C., Derijard, B., Davis, R., Johnson, G., and Karin, M. (1994). Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266, 1719-1723.
55. Minden, A., Lin, A., Smeal, T., Derijard, B., Cobb, M., Davis, R., and Karin, M. (1994). c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14, 6683-6688.
56. Minden, A., Lin, A., Claret, F.-X., Abo, A., and Karin, M. (1995). Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81, 1147-1157.
57. Muller, M., Strand, S., Hug, H., Heinemann, E.-M., Walczak, H., Hofmann, W., Stremmel, W., Krammer, P., and Galle, P. (1997). Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99, 403-413.
58. Muzio, M., Chinnayan, A.M., Kischkel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95(Fas/APO-1) death inducing signaling complex. Cell 85, 817-827.
59. Piret, B., and Piette, J. (1996). Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells. Nucleic Acids Res. 24, 4242-4248.
60. Reap, E.A., Roof, K., Maynor, K., Borrero, M., Booker, J., and Cohen, P.L. (1997). Radiation and stress-induced apoptosis: a role for Fas/ Fas ligand interactions. Proc. Natl. Acad. Sci. USA 94, 5750-5755.
61. Rosette, C., and Karin, M. (1996). Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274, 1194-1197.
62. Rosette, C., and Karin, M. (1995). Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-κB. J. Cell Biol. 128, 1111-1119.
63. Santana, P., Pena, L., Hriedman, A., Martin, S., Green, D., Mcloughlin, M., Cardo, C., Schuchman, E., Fuks, Z., and Kolesnick, R. (1996). Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189-199.
64. Seimiya, H., Mashima, T., Toho, M., and Tsuruo, T. (1997). c-Jun NH2-terminal kinase-mediated activation of interleukin-1b converting enzyme/CED3-like protease during anticancer drug-induced apoptosis. J. Biol. Chem. 272, 4631-4636.
65. Stein, B., Baldwin, A., Ballard, D., Greene, W., Angel, P., and Herrlich, P. (1993). Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12, 3879-3891.
66. Takahashi, T., Tanaka, M., Brannan, G.I., Jenkins, N.A., Copeland, N.G., Suda, T., and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
67. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T., and Nagata, S. (1994). Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6, 1567-1574.
68. Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M.S., Mak, T.W., and Taniguchi, T. (1994). Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77, 829-839.
69. Tillman, J.B., Crone, D.E., Kim, H.-S., Sprung, C.N., and Spindler, S.R. (1993). Promoter independent down-regulation of the firefly luciferase gene by T3 and T3 receptor in CV1 cells. Mol. Cell. Endocrinol. 95, 101-109.
70. Trent, J.C., McConkey, D.J., Loughlin, S.M., Harbison, M.T., Fernandez, A., and Ananthaswamy, H.N. (1996). Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J. 15, 4497-4505.
71. Van Antwerp, D.J., Martin, S., Kafri, T., Green, D.R., and Verma, I.M. (1996). Suppression of TNFα-induced apoptosis by NFκB. Science 274, 787-789.
72. Verheij, M., Bose, R., Lin, X., Yao, B., Jarvis, W., Grant, S., Birrer, M.J., Szabo, E., Zon, L., Kyriakis, J., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. (1996). Requirement of ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380, 75-79.
73. Wang, C.U., Mayo, M.W., and Baldwin, A.S. (1996). TNF-cancertherapy-induced apoptosis: potentiation by inhibition of NFκB. Science 274, 784-787.
74. Westwick, J., Weitzel, C., Minden, A., Karin, M., and Brenner, B. (1994). Tumor necrosis factor α stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269, 26396-26401.
75. Woronicz, J.D., Calnan, B., Ngo, V., and Winoto, A. (1994). Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367, 277-281.
76. Xia, Z., Dickens, M., Raingeaud, J., Davis, R., and Greenberg, M. (1995). Opposing effects of ERK and p38 MAP kinases on apoptosis. Science 270, 1326-1331.
77. Yang, Y., Mercep, M., Ware, C.F., and Ashwell, J.D. (1995). Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181, 1673-1682.
78. Yazdanbakhsh, K., Choi, J.-W., Li, Y., Lau, L.F., and Choi, Y. (1995). Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77. Proc. Natl. Acad. Sci. USA 92, 437-441.
79. Yonehara, S., Ishii, A., and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-down-regulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.